✦ LIBER ✦

Reasons for treating secondary AML as de novo AML

✍ Scribed by Lene Sofie Granfeldt Østgård; Eigil Kjeldsen; Mette Skov Holm; Peter De Nully Brown; Bjarne Bach Pedersen; Knud Bendix; Preben Johansen; Jørgen Schøler Kristensen; Jan Maxwell Nørgaard

Book ID: 114794789
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 300 KB
Volume: 85
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.2010.01464.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cytogenetic findings in adult secondary

Cytogenetic findings in adult secondary acute myeloid leukemia (AML): frequency of favorable and adverse chromosomal aberrations do not differ from adult de novo AML

✍ Birgitte S. Preiss; Olav J. Bergmann; Lone S. Friis; Anne G. Sørensen; Michael F 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 789 KB

Cytogenetic findings in adult secondary

Cytogenetic findings in adult secondary acute myeloid leukemia (AML): frequency of favorable and adverse chromosomal aberrations do not differ from adult de novo AML

📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 57 KB

Induction chemotherapy and post-remissio

Induction chemotherapy and post-remission imatinib therapy for de Novo BCR-ABL-positive AML

✍ Vladimir Lazarevic; Irina Golovleva; Ida Nygren; Anders Wahlin 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 285 KB

A NEW CASE OF DE NOVO AML WITH 9q INTERS

A NEW CASE OF DE NOVO AML WITH 9q INTERSTITIAL DELETION AS THE SOLE CHROMOSOMAL ABNORMALITY

✍ Nicole Smadja; Marcel Krulik; Aimery de Gramont; Gustavo Gonzalez; Canali J. Deb 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB

Long-term outcome of intensive chemother

Long-term outcome of intensive chemotherapy for adults with de novo acute myeloid leukaemia (AML): the nationwide AML-92 study by the Finnish Leukaemia Group

✍ Pirjo Koistinen; Riikka Räty; Maija Itälä; Esa Jantunen; Elli Koivunen; Tapio No 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 573 KB

Kinetic characteristics of de novo and s

Kinetic characteristics of de novo and secondary AML cells influence their response to haemopoietic growth factor (HGF) priming and correlate with clinical outcome

✍ M.Ann Smith; J Graham Smith; Chris J Pallister; Charles R.J Singer 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 113 KB